SPARQL
Query
Update
Search
Quick
Advanced
Co-occurrence
RelFinder
About
Sources
Admin
System Info
Repository Management
Search Configuration
Sources
21829040
Source:
http://linkedlifedata.com/resource/pubmed/id/21829040
Search
Subject
(
55
)
Predicate
Object
All
Download in:
JSON
RDF
N3/Turtle
N-Triples
Switch to
Custom View
Named Graph
All
UniProt
NCBIGene
DrugBank
ClinicalTrials
UMLS
PubMed
Mappings
MentionedEntities
Language
All
English
Español
Português
Français
Deutsch
Русский
日本語
Български
Inference
Explicit and implicit
Explicit only
Implicit only
Statements in which the resource exists as a subject.
Predicate
Object
rdf:type
pubmed:Citation
lifeskim:mentions
umls-concept:C0146224
,
umls-concept:C0205179
,
umls-concept:C0278579
,
umls-concept:C0282460
,
umls-concept:C0332174
,
umls-concept:C1511237
,
umls-concept:C1550436
,
umls-concept:C1705509
pubmed:issue
5-6
pubmed:dateCreated
2011-9-6
pubmed:abstractText
It was the aim of our study to evaluate the efficacy and safety of weekly topotecan in patients with advanced or recurrent cervical disease.
pubmed:language
eng
pubmed:journal
http://linkedlifedata.com/resource/pubmed/journal/0135054
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Antineoplastic Agents
,
http://linkedlifedata.com/resource/pubmed/chemical/Topoisomerase I Inhibitors
,
http://linkedlifedata.com/resource/pubmed/chemical/Topotecan
pubmed:status
MEDLINE
pubmed:issn
1423-0232
pubmed:author
pubmed-author:FuscoEE
,
pubmed-author:LorussoDD
,
pubmed-author:MainentiSS
,
pubmed-author:MalagutiPP
,
pubmed-author:MasciulloVV
,
pubmed-author:PietragallaAA
,
pubmed-author:ScambiaGG
pubmed:copyrightInfo
Copyright © 2011 S. Karger AG, Basel.
pubmed:issnType
Electronic
pubmed:volume
80
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
390-4
pubmed:meshHeading
pubmed-meshheading:21829040-Adenocarcinoma
,
pubmed-meshheading:21829040-Adult
,
pubmed-meshheading:21829040-Aged
,
pubmed-meshheading:21829040-Antineoplastic Agents
,
pubmed-meshheading:21829040-Carcinoma, Squamous Cell
,
pubmed-meshheading:21829040-Drug Administration Schedule
,
pubmed-meshheading:21829040-Female
,
pubmed-meshheading:21829040-Humans
,
pubmed-meshheading:21829040-Infusions, Intravenous
,
pubmed-meshheading:21829040-Injections, Intravenous
,
pubmed-meshheading:21829040-Middle Aged
,
pubmed-meshheading:21829040-Neoplasm Recurrence, Local
,
pubmed-meshheading:21829040-Neoplasm Staging
,
pubmed-meshheading:21829040-Topoisomerase I Inhibitors
,
pubmed-meshheading:21829040-Topotecan
,
pubmed-meshheading:21829040-Treatment Failure
,
pubmed-meshheading:21829040-Uterine Cervical Neoplasms
pubmed:year
2011
pubmed:articleTitle
Phase II study on weekly bolus topotecan in advanced or recurrent cervical cancer.
pubmed:affiliation
Department of Gynaecologic Oncology, Catholic University of the Sacred Heart, Largo Agostino Gemelli 8, Rome, Italy. kettalorusso@libero.it
pubmed:publicationType
Journal Article
,
Clinical Trial, Phase II